Invasive Pulmonary Aspergillosis in Coronavirus Disease 2019 Patients Lights and Shadows in the Current Landscape
Invasive pulmonary aspergillosis (IPA) presents a known risk to critically ill patients with SARS-CoV-2; quantifying the global burden of IPA in SARS-CoV-2 is extremely challenging. The true incidence of COVID-19-associated pulmonary aspergillosis (CAPA) and the impact on mortality is difficult to d...
Main Authors: | Stavros Tsotsolis, Serafeim-Chrysovalantis Kotoulas, Athina Lavrentieva |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Advances in Respiratory Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2543-6031/91/3/16 |
Similar Items
-
Subacute invasive pulmonary aspergillosis
by: Ravindran Chetambath
Published: (2021-01-01) -
Treatment Of Invasive Aspergillosis
by: İlknur ERDEM, et al.
Published: (2018-08-01) -
Invasive pulmonary aspergillosis is associated with cytomegalovirus viremia in critically ill patients - A retrospective cohort study
by: Chin-Wei Kuo, et al.
Published: (2022-04-01) -
Galactomannan antigen as one of the markers for the diagnosis of invasive aspergillosis
by: O.O. Yastremska, et al.
Published: (2019-12-01) -
Invasive Pulmonary Aspergillosis in HIV-Infected Children
by: N.V. Rymarenko
Published: (2014-02-01)